Aker Biomarine AS (AKBM) — Financial Flexibility Index
Aker Biomarine AS (AKBM) has a Financial Flexibility Index of -0.01x as of June 2025. Free cash flow of Nkr-2.30 Million (operating CF Nkr-6.90 Million minus capex Nkr4.60 Million) represents 0% of total liabilities (Nkr237.50 Million). Check Aker Biomarine AS PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aker Biomarine AS Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Aker Biomarine AS across 9 annual periods. See AKBM working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Aker Biomarine AS (2016–2024)
Year-by-year free cash flow to debt coverage for Aker Biomarine AS. For the full company profile including market capitalisation, see Aker Biomarine AS market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.17x | Nkr35.30 Million | Nkr12.20 Million | Nkr213.50 Million | ▼ -21.2% |
| 2023 | 0.21x | Nkr96.70 Million | Nkr47.40 Million | Nkr460.60 Million | ▲ +52.9% |
| 2022 | 0.14x | Nkr61.20 Million | Nkr15.10 Million | Nkr445.80 Million | ▼ -35.1% |
| 2021 | 0.21x | Nkr81.84 Million | Nkr729.00K | Nkr387.12 Million | ▲ +353.1% |
| 2020 | -0.08x | Nkr-27.33 Million | Nkr-51.04 Million | Nkr327.26 Million | ▼ -132.3% |
| 2019 | 0.26x | Nkr139.22 Million | Nkr12.31 Million | Nkr537.68 Million | ▼ -10.1% |
| 2018 | 0.29x | Nkr72.41 Million | Nkr7.89 Million | Nkr251.43 Million | ▼ -23.9% |
| 2017 | 0.38x | Nkr120.37 Million | Nkr9.17 Million | Nkr318.12 Million | ▲ +144.5% |
| 2016 | 0.15x | Nkr31.78 Million | Nkr20.88 Million | Nkr205.32 Million | — |